| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 8e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.07 |